Tryp

Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
Tryp Therapeutics (TRYP.C) announced they plan to conduct a Phase 2a clinical trial with the Chronic Pain & Fatigue Research Center at the University of Michigan Medical School. The study will…